Innovita Biological Technology Co., Ltd. (SHA:688253)

SHA:688253 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	368.81	307.73	166.46	388.67	479.74	482.06
Trading Asset Securities	1,609	1,584	1,531	1,115	87.25	114.26
Cash & Short-Term Investments	1,978	1,892	1,697	1,503	566.99	596.32
Cash Growth	8.74%	11.49%	12.89%	165.14%	-4.92%	488.42%
Accounts Receivable	14.12	37.83	105.17	124.31	4.13	9.05
Other Receivables	2.29	1.95	1.68	10.63	0.27	7.55
Receivables	16.42	39.78	106.86	134.95	4.4	16.6
Inventory	50.25	43.47	61.51	74.8	43.63	38.46
Other Current Assets	22.41	22.21	7.2	24.46	32.81	29.11
Total Current Assets	2,067	1,998	1,873	1,738	647.83	680.49
Property, Plant & Equipment	115.2	120.21	118.39	130.29	116.93	66.94
Long-Term Investments	16.54	35.65	34.26	14.94	5	-
Other Intangible Assets	6.73	6.79	7.02	7.25	7.49	3.49
Long-Term Deferred Tax Assets	21.45	22.65	13.41	2.26	1.22	1.71
Long-Term Deferred Charges	12.45	11.19	8.65	12.02	7.31	3.08
Other Long-Term Assets	33.74	18.42	11.31	38.3	12.1	24.35
Total Assets	2,273	2,212	2,066	1,943	797.87	780.06
Accounts Payable	103.63	90.93	63.57	71.56	21.16	9.15
Accrued Expenses	24.65	41.94	25.37	27.44	20.31	54.35
Short-Term Debt	-	-	-	17.62	-	8.8
Current Portion of Leases	2.73	3.2	1.96	3.01	0.88	-
Current Income Taxes Payable	2.53	0.95	16.34	4.31	2.64	19.41
Current Unearned Revenue	52.6	57.25	100.66	105.1	5.9	12.94
Other Current Liabilities	16.33	15.94	7.34	14.06	1.27	3.64
Total Current Liabilities	202.45	210.21	215.23	243.11	52.15	108.28
Long-Term Leases	2.4	2.57	1.04	2.49	0.52	-
Long-Term Unearned Revenue	2.74	3.14	4.8	6.33	6.99	3.77
Long-Term Deferred Tax Liabilities	2.95	3.15	2.58	1.31	0.05	-
Total Liabilities	210.54	219.07	223.65	253.24	59.7	112.05
Common Stock	136.46	136.46	136.06	136.06	102.04	102.04
Additional Paid-In Capital	1,038	1,036	1,024	1,022	255.67	255.4
Retained Earnings	970.23	874.94	682.51	531.15	380.46	310.21
Treasury Stock	-78.01	-50.01	-	-	-	-
Comprehensive Income & Other	-3.69	-3.65	-1.02	-	-	-
Total Common Equity	2,063	1,993	1,842	1,689	738.17	667.65
Minority Interest	-	-	-	-	-	0.36
Shareholders' Equity	2,063	1,993	1,842	1,689	738.17	668.01
Total Liabilities & Equity	2,273	2,212	2,066	1,943	797.87	780.06
Total Debt	5.13	5.77	3	23.12	1.4	8.8
Net Cash (Debt)	1,973	1,886	1,694	1,480	565.59	587.53
Net Cash Growth	8.64%	11.35%	14.45%	161.71%	-3.73%	482.62%
Net Cash Per Share	14.47	13.83	12.47	12.18	5.55	5.93
Filing Date Shares Outstanding	136.46	134.87	136.06	136.06	102.04	102.04
Total Common Shares Outstanding	136.46	134.87	136.06	136.06	102.04	102.04
Working Capital	1,864	1,787	1,657	1,494	595.68	572.21
Book Value Per Share	15.11	14.78	13.54	12.42	7.23	6.54
Tangible Book Value	2,056	1,987	1,835	1,682	730.68	664.16
Tangible Book Value Per Share	15.07	14.73	13.49	12.36	7.16	6.51
Buildings	-	97.96	97.96	94.67	85.39	50.22
Machinery	-	98.21	86.21	77.17	61.21	33.97
Construction In Progress	-	2.37	-	-	0.2	2.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.